Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Bermuda.
Press releases published on July 28, 2025
EIN Presswire Debuts Podcast with PR Insider Sherrie Handrinos on the Power of Influencer Marketing
EIN Presswire
·
July 28, 2025
“Heard on the Streets” podcast explores how brands are cashing in on social media strategy WASHINGTON , DC, UNITED STATES, July 28, 2025 /EINPresswire.com/ -- EIN Presswire has launched its first audio podcast on Substack, and it’s diving into one of …
QCI Co-Founders Andrew Cardno and Dr. Ralph Thomas Reunite with VizExplorer
GlobeNewswire
·
July 28, 2025
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) today announced the acquisition of VizExplorer, bringing the acclaimed casino analytics platform back under the leadership of its original visionaries, Dr. Ralph Thomas and Andrew …
FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
GlobeNewswire
·
July 28, 2025
Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits Broad label includes adults and adolescents with C3G or primary IC-MPGN, and post-transplant …
Chicken Road Game In India 2025 - Login, Play and Win Real Money
GlobeNewswire
·
July 28, 2025
Gurugram, Haryana, July 28, 2025 (GLOBE NEWSWIRE) -- Chicken Road is quickly rising to the top in India as one of the most exciting crash-style games in the online gambling world. It is attracting massive popularity in 2025 due to its simple-to-grasp rules …
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
GlobeNewswire
·
July 28, 2025
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Company …
Early Warrant Expiration: Preliminary Notice
GlobeNewswire
·
July 28, 2025
Price of Enovix common stock has exceeded $10.50 for five trading days The earliest expiration date for the Warrants is August 19, 2025 Reserves right to set Alternate Expiration Date for Warrants FREMONT, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- …
Azerion Announces Additional Share Purchases by Leadership Team Members
GlobeNewswire
·
July 28, 2025
Amsterdam, 28 July 2025 - Azerion announces that it has been informed that several members of its Executive Committee along with other members of the operational leadership team have mandated or will mandate Arctic Securities to acquire shares in the …
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
GlobeNewswire
·
July 28, 2025
Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company’s History International Cannabis Revenue Increased 71% in Q4 …
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
GlobeNewswire
·
July 28, 2025
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical …
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
GlobeNewswire
·
July 28, 2025
Informations Réglementées Châtillon, France, le 28 juillet (22 h 30 CET) 2025 Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), laboratoire biopharmaceutique …
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
GlobeNewswire
·
July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced …
BullFrog AI to Present at BTIG Annual Virtual Biotechnology Conference
GlobeNewswire
·
July 28, 2025
GAITHERSBURG, Md., July 28, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence ("AI") and machine learning to enable the …
Abivax Announces Closing of $747.5 Million Public Offering
GlobeNewswire
·
July 28, 2025
Abivax Announces Closing of $747.5 Million Public Offering PARIS, France, July 28, 2025 – 10:15 p.m. (CEST) – Abivax SA (Euronext Paris: FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing …
Dyne Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 28, 2025
- Expected cash runway extended into Q3 2027, beyond multiple potential inflection points including Dyne’s first planned commercial launch in early 2027 - - Registrational Expansion Cohort of DELIVER Trial of DYNE-251 in DMD fully enrolled to support …
iMDx to Host Virtual KOL Event to Discuss its In-House dd-cfDNA Testing for Kidney Transplant Patients on August 15, 2025
GlobeNewswire
·
July 28, 2025
NASHVILLE, Tenn., July 28, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics, or iMDx, (Nasdaq: IMDX), today announced that it will host a virtual key opinion leader (KOL) event on Friday, August 15, 2025 at 4:00 PM ET featuring Anthony Langone, MD ( …
Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025
GlobeNewswire
·
July 28, 2025
BASEL, Switzerland and LONDON and NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, August 11, 2025, to report its financial results for the …
Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
GlobeNewswire
·
July 28, 2025
CAMBRIDGE, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare …
OrbimountAI Launches Next-Gen IT Management Platform Delivering High ROI for SMBs
GlobeNewswire
·
July 28, 2025
London UK, July 28, 2025 (GLOBE NEWSWIRE) -- In today’s fast-moving digital economy, small and mid-sized businesses are searching for reliable IT partners that deliver measurable results. According to recent Orbimount reviews, the company is rapidly …
Official Launch: MulfinTradeAi App Delivers Intelligent AI-Driven Signals for Traders Worldwide
GlobeNewswire
·
July 28, 2025
London, UK , July 28, 2025 (GLOBE NEWSWIRE) -- The MulfinTradeAi App is setting a new benchmark for automated trading in raw materials and global equity markets. With advanced machine learning algorithms and predictive analytics, the platform provides real …
Neurogen Biomarking Virtual Care Ecosystem Cuts Time to Alzheimer’s Intervention by 4.5 Years, AAIC 2025 Presentation Findings Show
GlobeNewswire
·
July 28, 2025
Progress in validating in-home blood test, combined with cognitive assessment and specialty virtual care, break through barriers to early detection Key Takeaways Findings from breakthrough approach to early detection for Alzheimer’s disease (AD) has the …